For citations:
Levina V.D., Poltavskaya M.G., Chomakhidze P.Sh., Meshcheryakov A.A., Bolotina L.V., Deshkina T.I., Valiulina D.S., Gerasimov A.N., Andreeva O.V., Shmeleva A.A., Fashafsha Z., Levshina A.R., Sedov V.P. High-sensitivity troponin I as a predictor of left ventricular dysfunction in the use of cardiotoxic anticancer agents for breast cancer in patients with predominantly low and moderate risk of cardiotoxicity. Russian Journal of Cardiology. 2022;27(11):5210. (In Russ.) https://doi.org/10.15829/1560-4071-2022-5210
Email this article 